GER:4AB

ABBVIE INC. Stock Insider Trading

Deutsche Börse XETRA > Healthcare > Drug Manufacturers—General

Open Broker Account

147.62€

-3.22 (-2.13%)

At Close: May 22, 2024

There is currently no insider trading information for this ticker.

However, we invite you to learn more about this term and how to use this knowledge to benefit your trading strategy:

Sorry! Image not available at this moment

About ABBVIE INC.

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia ... 4AB.DE Profile

Golden Star

Ticker	Date	Change	Price
GWW	May 20	1.10%	$953.40
OHI	May 20	3.43%	$30.86
CNI	May 16	0.751%	$126.57
TTWO	May 16	3.10%	$146.08
LYV	May 16	5.21%	$96.38
INBX	May 15	0.116%	$34.37
LNG	May 14	0.93%	$157.42
CME	May 14	0.323%	$210.80
VGIT	May 14	0.104%	$57.83
VCLT	May 14	0.87%	$75.73

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by

Sign In

ABBVIE INC. Stock Insider Trading

About ABBVIE INC.

Golden Star

Top Fintech Company